Health
Moderna cuts 2021 sales forecast for COVID-19 vaccine; shares tumble – The Japan Times
Moderna said it was now expecting sales of between $15 billion and $18 billion from $20 billion estimated previously.
Moderna Inc. on Thursday cut its 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, as it struggles to ramp up production of its two-dose inoculation, sending its shares down nearly 11% in premarket trading.
The company’s sales target…
Continue Reading
-
General7 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General5 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business5 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General8 hours agoAlbanese beats drum on economy as trade clouds gather